Do analysts prefer WLKP or AVNT?

Avient has a consensus target price of $46.40, suggesting a potential upside of 30.83%. Given Avient's higher possible upside, analysts clearly believe Avient is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Avient 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend NGVT or WLKP?

Ingevity currently has a consensus price target of $80.00, indicating a potential upside of 17.92%. Given Ingevity's higher probable upside, equities analysts clearly believe Ingevity is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ingevity 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts prefer PCT or WLKP?

PureCycle Technologies currently has a consensus price target of $12.00, suggesting a potential downside of 3.15%. Given PureCycle Technologies' higher probable upside, research analysts plainly believe PureCycle Technologies is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureCycle Technologies 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts recommend WLKP or BAK?

Braskem has a consensus target price of $3.40, suggesting a potential downside of 18.74%. Given Braskem's higher possible upside, analysts clearly believe Braskem is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Braskem 4 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.63

Do analysts rate WLKP or ECVT?

Ecovyst has a consensus price target of $14.20, suggesting a potential upside of 7.57%. Given Ecovyst's higher probable upside, analysts clearly believe Ecovyst is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Ecovyst 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Westlake Chemical Partners (WLKP) Competitors

$22.92 -0.01 (-0.03%)

Closing price 05/29/2026 03:58 PM Eastern

Extended Trading

$22.94 +0.02 (+0.10%)

As of 07:01 AM Eastern

Compare

WLKP vs. AVNT, NGVT, PCT, BAK, and ECVT

Should you buy Westlake Chemical Partners stock or one of its competitors? MarketBeat compares Westlake Chemical Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Westlake Chemical Partners include Avient (AVNT), Ingevity (NGVT), PureCycle Technologies (PCT), Braskem (BAK), and Ecovyst (ECVT). These companies are all part of the "chemicals" industry.

How does Westlake Chemical Partners compare to Avient?

Westlake Chemical Partners (NYSE:WLKP) and Avient (NYSE:AVNT) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Avient has a net margin of 4.81% compared to Westlake Chemical Partners' net margin of 4.69%. Avient's return on equity of 11.11% beat Westlake Chemical Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Westlake Chemical Partners	4.69%	7.15%	4.57%
Avient	4.81%	11.11%	4.40%

Avient has higher revenue and earnings than Westlake Chemical Partners. Westlake Chemical Partners is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Westlake Chemical Partners	$1.17B	0.69	$48.70M	$1.64	13.98
Avient	$3.26B	1.00	$81.90M	$1.72	20.62

Westlake Chemical Partners pays an annual dividend of $1.89 per share and has a dividend yield of 8.2%. Avient pays an annual dividend of $1.10 per share and has a dividend yield of 3.1%. Westlake Chemical Partners pays out 115.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Avient pays out 64.0% of its earnings in the form of a dividend. Avient has raised its dividend for 1 consecutive years.

In the previous week, Westlake Chemical Partners' average media sentiment score of 0.00 equaled Avient'saverage media sentiment score.

Company	Overall Sentiment
Westlake Chemical Partners	Neutral
Avient	Neutral

Avient has a consensus target price of $46.40, suggesting a potential upside of 30.83%. Given Avient's higher possible upside, analysts clearly believe Avient is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Avient	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

78.3% of Westlake Chemical Partners shares are owned by institutional investors. Comparatively, 95.5% of Avient shares are owned by institutional investors. 1.1% of Westlake Chemical Partners shares are owned by insiders. Comparatively, 0.9% of Avient shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Westlake Chemical Partners has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Avient has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market.

Summary

Avient beats Westlake Chemical Partners on 13 of the 17 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Ingevity?

Ingevity (NYSE:NGVT) and Westlake Chemical Partners (NYSE:WLKP) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Ingevity has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market. Comparatively, Westlake Chemical Partners has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

Westlake Chemical Partners has a net margin of 4.69% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Westlake Chemical Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	-10.55%	207.82%	9.70%
Westlake Chemical Partners	4.69%	7.15%	4.57%

91.6% of Ingevity shares are owned by institutional investors. Comparatively, 78.3% of Westlake Chemical Partners shares are owned by institutional investors. 0.9% of Ingevity shares are owned by insiders. Comparatively, 1.1% of Westlake Chemical Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Ingevity's average media sentiment score of 0.00 equaled Westlake Chemical Partners'average media sentiment score.

Company	Overall Sentiment
Ingevity	Neutral
Westlake Chemical Partners	Neutral

Ingevity currently has a consensus price target of $80.00, indicating a potential upside of 17.92%. Given Ingevity's higher probable upside, equities analysts clearly believe Ingevity is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Westlake Chemical Partners has lower revenue, but higher earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.02	-$167.10M	-$3.55	N/A
Westlake Chemical Partners	$1.17B	0.69	$48.70M	$1.64	13.98

Summary

Ingevity beats Westlake Chemical Partners on 8 of the 14 factors compared between the two stocks.

How does Westlake Chemical Partners compare to PureCycle Technologies?

PureCycle Technologies (NASDAQ:PCT) and Westlake Chemical Partners (NYSE:WLKP) are both chemicals companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

Westlake Chemical Partners has higher revenue and earnings than PureCycle Technologies. PureCycle Technologies is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PureCycle Technologies	$8.35M	268.37	-$182.57M	-$1.47	N/A
Westlake Chemical Partners	$1.17B	0.69	$48.70M	$1.64	13.98

PureCycle Technologies has a beta of 2.48, suggesting that its stock price is 148% more volatile than the broader market. Comparatively, Westlake Chemical Partners has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

PureCycle Technologies currently has a consensus price target of $12.00, suggesting a potential downside of 3.15%. Given PureCycle Technologies' higher probable upside, research analysts plainly believe PureCycle Technologies is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PureCycle Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Westlake Chemical Partners has a net margin of 4.69% compared to PureCycle Technologies' net margin of -2,062.36%. Westlake Chemical Partners' return on equity of 7.15% beat PureCycle Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PureCycle Technologies	-2,062.36%	-393.01%	-22.56%
Westlake Chemical Partners	4.69%	7.15%	4.57%

63.0% of PureCycle Technologies shares are owned by institutional investors. Comparatively, 78.3% of Westlake Chemical Partners shares are owned by institutional investors. 18.8% of PureCycle Technologies shares are owned by insiders. Comparatively, 1.1% of Westlake Chemical Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, PureCycle Technologies had 6 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 6 mentions for PureCycle Technologies and 0 mentions for Westlake Chemical Partners. PureCycle Technologies' average media sentiment score of 0.39 beat Westlake Chemical Partners' score of 0.00 indicating that PureCycle Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
PureCycle Technologies	Neutral
Westlake Chemical Partners	Neutral

Summary

Westlake Chemical Partners beats PureCycle Technologies on 8 of the 15 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Braskem?

Westlake Chemical Partners (NYSE:WLKP) and Braskem (NYSE:BAK) are both small-cap chemicals companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Westlake Chemical Partners has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Westlake Chemical Partners	$1.17B	0.69	$48.70M	$1.64	13.98
Braskem	$12.66B	0.13	-$1.77B	-$4.22	N/A

Westlake Chemical Partners has a net margin of 4.69% compared to Braskem's net margin of -13.72%. Westlake Chemical Partners' return on equity of 7.15% beat Braskem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Westlake Chemical Partners	4.69%	7.15%	4.57%
Braskem	-13.72%	-23.17%	2.72%

78.3% of Westlake Chemical Partners shares are held by institutional investors. 1.1% of Westlake Chemical Partners shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Westlake Chemical Partners has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Braskem has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

In the previous week, Braskem had 2 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 2 mentions for Braskem and 0 mentions for Westlake Chemical Partners. Westlake Chemical Partners' average media sentiment score of 0.00 beat Braskem's score of -0.12 indicating that Westlake Chemical Partners is being referred to more favorably in the media.

Company	Overall Sentiment
Westlake Chemical Partners	Neutral
Braskem	Neutral

Braskem has a consensus target price of $3.40, suggesting a potential downside of 18.74%. Given Braskem's higher possible upside, analysts clearly believe Braskem is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Braskem	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.63

Summary

Westlake Chemical Partners beats Braskem on 11 of the 15 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Ecovyst?

Westlake Chemical Partners (NYSE:WLKP) and Ecovyst (NYSE:ECVT) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

Westlake Chemical Partners has higher revenue and earnings than Ecovyst. Ecovyst is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Westlake Chemical Partners	$1.17B	0.69	$48.70M	$1.64	13.98
Ecovyst	$723.50M	2.00	-$71.13M	-$0.55	N/A

Westlake Chemical Partners has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Ecovyst has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market.

78.3% of Westlake Chemical Partners shares are owned by institutional investors. Comparatively, 86.7% of Ecovyst shares are owned by institutional investors. 1.1% of Westlake Chemical Partners shares are owned by insiders. Comparatively, 1.8% of Ecovyst shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Westlake Chemical Partners has a net margin of 4.69% compared to Ecovyst's net margin of -7.71%. Ecovyst's return on equity of 11.58% beat Westlake Chemical Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Westlake Chemical Partners	4.69%	7.15%	4.57%
Ecovyst	-7.71%	11.58%	4.76%

Ecovyst has a consensus price target of $14.20, suggesting a potential upside of 7.57%. Given Ecovyst's higher probable upside, analysts clearly believe Ecovyst is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ecovyst	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Ecovyst had 3 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 3 mentions for Ecovyst and 0 mentions for Westlake Chemical Partners. Ecovyst's average media sentiment score of 0.35 beat Westlake Chemical Partners' score of 0.00 indicating that Ecovyst is being referred to more favorably in the news media.

Company	Overall Sentiment
Westlake Chemical Partners	Neutral
Ecovyst	Neutral

Summary

Ecovyst beats Westlake Chemical Partners on 10 of the 15 factors compared between the two stocks.

Get Westlake Chemical Partners News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WLKP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WLKP vs. The Competition

Export

Metric	Westlake Chemical Partners	CHEM Industry	Materials Sector	NYSE Exchange
Market Cap	$808M	$15.13B	$4.93B	$23.18B
Dividend Yield	8.22%	1.94%	4.94%	4.09%
P/E Ratio	13.98	35.08	23.65	30.62
Price / Sales	0.69	2.51	7,478.76	24.75
Price / Cash	4.57	14.68	24.41	19.43
Price / Book	1.01	4.75	9.57	4.70
Net Income	$48.70M	$376.44M	$156.62M	$1.07B
7 Day Performance	1.65%	1.60%	1.77%	1.14%
1 Month Performance	N/A	N/A	24.17%	1.58%
1 Year Performance	3.46%	21.92%	77.74%	28.06%

Westlake Chemical Partners Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WLKP Westlake Chemical Partners	2.3282 of 5 stars	$22.92 0.0%	N/A	+3.5%	$808M	$1.17B	13.98	150
AVNT Avient	4.6538 of 5 stars	$32.59 -2.9%	$46.40 +42.4%	-1.8%	$2.99B	$3.26B	18.95	9,000	Positive News
NGVT Ingevity	2.3493 of 5 stars	$65.00 -2.3%	$80.00 +23.1%	+64.0%	$2.26B	$1.17B	N/A	1,500
PCT PureCycle Technologies	1.2142 of 5 stars	$12.29 -4.2%	$12.00 -2.4%	+31.5%	$2.22B	$8.35M	N/A	120
BAK Braskem	1.9008 of 5 stars	$4.85 -3.5%	$3.40 -29.8%	+10.4%	$1.93B	$12.66B	N/A	8,233

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WLKP) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Westlake Chemical Partners (WLKP) Competitors

WLKP vs. AVNT, NGVT, PCT, BAK, and ECVT

How does Westlake Chemical Partners compare to Avient?

Summary

How does Westlake Chemical Partners compare to Ingevity?

Summary

How does Westlake Chemical Partners compare to PureCycle Technologies?

Summary

How does Westlake Chemical Partners compare to Braskem?

Summary

How does Westlake Chemical Partners compare to Ecovyst?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WLKP vs. The Competition

Westlake Chemical Partners Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Westlake Chemical Partners (WLKP) Competitors

WLKP vs. AVNT, NGVT, PCT, BAK, and ECVT

How does Westlake Chemical Partners compare to Avient?

Is WLKP or AVNT more profitable?

Which has preferable valuation and earnings, WLKP or AVNT?

Is WLKP or AVNT a better dividend stock?

Does the media prefer WLKP or AVNT?

Do analysts prefer WLKP or AVNT?

Do institutionals & insiders have more ownership in WLKP or AVNT?

Which has more risk & volatility, WLKP or AVNT?

Summary

How does Westlake Chemical Partners compare to Ingevity?

Which has more risk & volatility, NGVT or WLKP?

Is NGVT or WLKP more profitable?

Do institutionals and insiders believe in NGVT or WLKP?

Does the media refer more to NGVT or WLKP?

Do analysts recommend NGVT or WLKP?

Which has preferable earnings & valuation, NGVT or WLKP?

Summary

How does Westlake Chemical Partners compare to PureCycle Technologies?

Which has better earnings and valuation, PCT or WLKP?

Which has more risk & volatility, PCT or WLKP?

Do analysts prefer PCT or WLKP?

Is PCT or WLKP more profitable?

Do institutionals & insiders hold more shares of PCT or WLKP?

Does the media prefer PCT or WLKP?

Summary

How does Westlake Chemical Partners compare to Braskem?

Which has preferable valuation & earnings, WLKP or BAK?

Is WLKP or BAK more profitable?

Do institutionals and insiders hold more shares of WLKP or BAK?

Which has more volatility and risk, WLKP or BAK?

Does the media favor WLKP or BAK?

Do analysts recommend WLKP or BAK?

Summary

How does Westlake Chemical Partners compare to Ecovyst?

Which has preferable earnings & valuation, WLKP or ECVT?

Which has more volatility and risk, WLKP or ECVT?

Do insiders and institutionals hold more shares of WLKP or ECVT?

Is WLKP or ECVT more profitable?

Do analysts rate WLKP or ECVT?

Does the media favor WLKP or ECVT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WLKP vs. The Competition

Westlake Chemical Partners Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools